- Home
- VLY vs ACLX Comparison
VLY vs ACLX Comparison
Compare VLY & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- ACLX
- Stock Information
- Founded
- VLY 1927
- ACLX 2015
- Country
- VLY United States
- ACLX United States
- Employees
- VLY N/A
- ACLX N/A
- Industry
- VLY Major Banks
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- VLY Finance
- ACLX Health Care
- Exchange
- VLY Nasdaq
- ACLX Nasdaq
- Market Cap
- VLY 5.2B
- ACLX 4.4B
- IPO Year
- VLY N/A
- ACLX 2022
- Fundamental
- Price
- VLY $10.93
- ACLX $87.51
- Analyst Decision
- VLY Buy
- ACLX Strong Buy
- Analyst Count
- VLY 15
- ACLX 13
- Target Price
- VLY $12.80
- ACLX $114.38
- AVG Volume (30 Days)
- VLY 15.4M
- ACLX 475.1K
- Earning Date
- VLY 10-23-2025
- ACLX 11-05-2025
- Dividend Yield
- VLY 4.03%
- ACLX N/A
- EPS Growth
- VLY 40.78
- ACLX N/A
- EPS
- VLY 0.88
- ACLX N/A
- Revenue
- VLY $1,704,193,000.00
- ACLX $56,979,000.00
- Revenue This Year
- VLY $33.72
- ACLX N/A
- Revenue Next Year
- VLY $10.10
- ACLX $220.95
- P/E Ratio
- VLY $12.43
- ACLX N/A
- Revenue Growth
- VLY 8.06
- ACLX N/A
- 52 Week Low
- VLY $7.48
- ACLX $47.86
- 52 Week High
- VLY $11.35
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- VLY 55.26
- ACLX 55.15
- Support Level
- VLY $10.67
- ACLX $84.00
- Resistance Level
- VLY $10.93
- ACLX $92.34
- Average True Range (ATR)
- VLY 0.35
- ACLX 3.69
- MACD
- VLY 0.03
- ACLX -0.29
- Stochastic Oscillator
- VLY 74.39
- ACLX 50.21
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.